These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 8325045
1. Clinical tolerance of a combined monophasic contraceptive agent containing a low-dose of ethinyloestradiol and gestodene in adolescents. Leonard F, Gaspard U, Theunissen L. Curr Med Res Opin; 1993; 13(2):78-86. PubMed ID: 8325045 [Abstract] [Full Text] [Related]
2. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance. Endrikat J, Müller U, Düsterberg B. Contraception; 1997 Mar; 55(3):131-7. PubMed ID: 9115000 [Abstract] [Full Text] [Related]
3. Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women. Gaspard UJ, Deville JL, Dubois M. Curr Med Res Opin; 1983 Mar; 8(6):395-404. PubMed ID: 6406157 [Abstract] [Full Text] [Related]
7. Open prospective multicenter trial with a new monophasic contraceptive combination containing gestodene. Renier M, Buytaert P. Contraception; 1991 May; 43(5):413-21. PubMed ID: 1914456 [Abstract] [Full Text] [Related]
9. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women. Koetsawang S, Charoenvisal C, Banharnsupawat L, Singhakovin S, Kaewsuk O, Punnahitanont S. Contraception; 1995 Apr; 51(4):225-9. PubMed ID: 7796587 [Abstract] [Full Text] [Related]
14. Comparative study on the acceptability of two modern monophasic oral contraceptive preparations: 30 microgram ethinyl estradiol combined with 150 microgram desogestrel or 75 microgram gestodene. Zichella L, Sbrignadello C, Tomassini A, Di Lieto A, Montoneri C, Zarbo G, Mancone M, Pietrobattista P, Bertoli G, Perrone G. Adv Contracept; 1999 Apr; 15(3):191-200. PubMed ID: 11019950 [Abstract] [Full Text] [Related]
15. Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum. Kuhnz W, Baumann A, Staks T, Dibbelt L, Knuppen R, Jütting G. Contraception; 1993 Oct; 48(4):303-22. PubMed ID: 8222659 [Abstract] [Full Text] [Related]
16. Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women. Paoletti AM, Orrù M, Floris S, Mannias M, Vacca AM, Ajossa S, Guerriero S, Melis GB. Contraception; 2000 Apr; 61(4):259-63. PubMed ID: 10899481 [Abstract] [Full Text] [Related]
19. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol. Hammerstein J, Daume E, Simon A, Winkler UH, Schindler AE, Back DJ, Ward S, Neiss A. Contraception; 1993 Mar; 47(3):263-81. PubMed ID: 8462317 [Abstract] [Full Text] [Related]
20. Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives. Hamerlynck JV, Vollebregt JA, Doornebos CM, Muntendam P. Contraception; 1987 Mar; 35(3):199-205. PubMed ID: 2956054 [Abstract] [Full Text] [Related] Page: [Next] [New Search]